Matt routinely works with large multinational life sciences companies on a variety of issues that impact their international supply chain, including:

• Customs classification issues related to medical device spare parts and servicing
• Coordination among FDA, Customs and other government agencies regarding imports of highly regulated biologic and non-biologic materials
• Negotiation of contract manufacturing agreements for medical device components and active pharmaceutical ingredients
• Import security and physical requirements for companies importing toxic or hazardous materials
• Negotiation of technology transfer agreements